Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.

AIMS In chronic heart failure (CHF), reduced vagal activity correlates with increased mortality and acute decompensation. Experimentally, chronic vagus nerve stimulation (VNS) improved left ventricular (LV) function and survival; clinically, it is used for the treatment of drug-refractory epilepsy. We assessed safety and tolerability of chronic VNS in symptomatic CHF patients, using a novel implantable nerve stimulation system. The secondary goal was to obtain preliminary data on clinical efficacy. METHODS AND RESULTS This multi-centre, open-label phase II, two-staged study (8-patient feasibility phase plus 24-patient safety and tolerability phase) enrolled 32 New York Heart Association (NYHA) class II-IV patients [age 56 ± 11 years, LV ejection fraction (LVEF) 23 ± 8%]. Right cervical VNS with CardioFit (BioControl Medical) implantable system started 2-4 weeks after implant, slowly raising intensity; patients were followed 3 and 6 months thereafter with optional 1-year follow-up. Overall, 26 serious adverse events (SAEs) occurred in 13 of 32 patients (40.6%), including three deaths and two clearly device-related AEs (post-operative pulmonary oedema, need of surgical revision). Expected non-serious device-related AEs (cough, dysphonia, and stimulation-related pain) occurred early but were reduced and disappeared after stimulation intensity adjustment. There were significant improvements (P < 0.001) in NYHA class quality of life, 6-minute walk test (from 411 ± 76 to 471 ± 111 m), LVEF (from 22 ± 7 to 29 ± 8%), and LV systolic volumes (P = 0.02). These improvements were maintained at 1 year. CONCLUSIONS This open-label study shows that chronic VNS in CHF patients with severe systolic dysfunction may be safe and tolerable and may improve quality of life and LV function. A controlled clinical trial appears warranted.

[1]  Zoran B. Popović,et al.  Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model , 2009, Circulation. Heart failure.

[2]  H. Sabbah,et al.  509 Therapy with Vagus nerve electrical stimulation combined with beta‐blockade improves left ventricular systolic function in dogs with heart failure beyond that seen with beta‐blockade alone , 2007 .

[3]  Luigi Tavazzi,et al.  Long term vagal stimulation in patients with advanced heart failure First experience in man , 2008, European journal of heart failure.

[4]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[5]  Brian Olshansky,et al.  Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. , 2008, Circulation.

[6]  P. Schwartz,et al.  Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. , 1988, Circulation.

[7]  P. Schwartz,et al.  Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. , 1993, Journal of the American College of Cardiology.

[8]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[9]  E. Ben-Menachem,et al.  Vagus Nerve Stimulation, Side Effects, and Long-Term Safety , 2001, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[10]  Steven C Schachter,et al.  Vagus nerve stimulation therapy summary: Five years after FDA approval , 2002, Neurology.

[11]  P. Schwartz,et al.  Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. , 2007, Journal of the American College of Cardiology.

[12]  H. L. Stone,et al.  The effects of daily exercise on susceptibility to sudden cardiac death. , 1984, Circulation.

[13]  Masaru Sugimachi,et al.  Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats , 2003, Circulation.

[14]  W. Abraham,et al.  Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.

[15]  Hani N. Sabbah,et al.  RIGHT VAGUS NERVE STIMULATION IMPROVES LEFT VENTRICULAR FUNCTION IN DOGS WITH HEART FAILURE , 2010 .

[16]  S. S. Hull,et al.  Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. , 1991, The American journal of physiology.

[17]  M. Shuchman.  Approving the vagus-nerve stimulator for depression. , 2007, The New England journal of medicine.

[18]  Peter J. Schwartz,et al.  Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions , 2011, Heart Failure Reviews.

[19]  Andrew S. Wechsler,et al.  Relief of Angina Pectoris by Electrical Stimulation of the Carotid-Sinus Nerves , 1967 .

[20]  M. N. Levy,et al.  Vagal Control of the Heart: Experimental Basis and Clinical Implications , 1994 .

[21]  A. Milby,et al.  Vagus nerve stimulation for epilepsy and depression , 2011, Neurotherapeutics.

[22]  G D Pinna,et al.  Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. , 1997, Circulation.

[23]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[24]  Jeroen J. Bax,et al.  Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy , 2005, Circulation.

[25]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[26]  S I Schwartz,et al.  Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. , 1967, American journal of surgery.

[27]  S. S. Hull,et al.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.

[28]  William T. Abraham,et al.  Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure , 2003 .